Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search Materials

A library of resources for the prevention,
management, and elimination of TB.

Showing 1 - 15 of 26 Results

Number of items to view
Filter Your Results
Title Year

This information sheet provides essential information about tuberculosis (TB), including its causes, how it spreads, and the differences between latent TB infection (LTBI) and active TB disease. It outlines testing methods, treatment options, and the importance of early diagnosis and adherence to treatment to prevent transmission...

Health Professionals Physicians
2024

This info sheet summarizes the updated 2020 LTBI treatment guidelines that apply to persons with LTBI who live in the United States

Health Professionals
2020

This tool provides a daily Rifampin Schedule for Latent Tuberculosis (TB) patients.

Persons with TB
2020

This fact sheet provides information regarding the 12-dose regimen for treating latent TB infection.

At Risk Persons General Public Non-U.S.-born persons Persons with TB
2016

This information sheet presents a chart of the expense involved in the treatment of multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TB. It depicts the financial toll of MDR and XDR TB; the human cost of those being treated including death, inability to work, hospitalization, and isolation; and the serious physical and mental side effects that accompany treatment...

Persons with TB
2014

This information sheet discusses multidrug-resistant TB (MDR TB), a strain of TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. It describes TB disease, MDR TB, extensively drug resistant TB (XDR TB), TB transmission, how drug resistance happens, and who is at risk for getting MDR TB...

2012

This information sheet discusses infection control measures for health care settings to ensure prompt detection, take airborne precautions, and treat persons with suspected or diagnosed tuberculosis infection. It suggests that policies and procedures for TB control should be developed, reviewed periodically, and evaluated to minimize transmission risk...

2012

This information sheet discusses TB and the risk for international travelers. It explains TB transmission, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of the disease, and how drug resistance occurs. The information sheet considers whether international travelers are at risk of MDR or XDR TB while traveling, the risk of acquiring TB on an airplane, how TB can be prevented, TB vaccine, and what an individual should do before traveling internationally and if an individual thinks that he/she may have been exposed to someone with TB disease...

General Public
2012

This information sheet explains TB for employers in non-healthcare settings. It describes TB disease, latent TB infection (LTBI), active TB, how it is determined whether a patient has active TB or LTBI, the symptoms of TB, what one should do if an employee reports having positive TB or has been in contact with someone with TB, and what happens after the employer contacts the local or state TB program...

General Public
2012

This fact sheet discusses TB and how it is affected by the HIV. It defines TB and explains the difference between TB infection and latent TB infection. The fact sheet advises that HIV weakens the immune system increasing the chance that in people with HIV and latent TB, the TB germs will become active and attack the body causing TB disease...

General Public
2012

Using a question and answer format, this fact sheet provides general information on TB prevention. It discusses TB transmission, infection, disease, diagnosis through a skin test or a special TB blood test, and treatment. It explains that TB is spread by germs that are in the air after someone with TB disease sneezes, coughs, speaks, laughs, or sings...

Persons who inject drugs
2012

This information sheet discusses the once-a-week 12-week treatment of rifapentine and isoniazid for latent TB infection (LTBI). It explains LTBI, why it is necessary to treat it, the treatment plan and how it is managed, and a chart for tracking. It also includes hints on how to take the medicine including eating before taking it and avoiding alcohol, and describes normal side effects and possible problems including which signs and symptoms require you to call the doctor or nurse and what to do when taking a dose of medicine in the absence of medical staff...

General Public
2012

This information sheet discusses treatment for latent TB infection. It reminds patients to keep their weekly medical visits, explains directly observed therapy, provides a list of items to discuss with their doctor, a medication schedule, and advises them to call the doctor immediately if they experience any of the side effects on the list...

General Public Persons With LTBI
2012

This information sheet discusses the treatment of TB disease in individuals who are not infected with HIV and who are not resistant to any of the drugs used to treat TB disease. It follows the guidelines released in 2003 by the American Thoracic Society, CDC, and the Infectious Diseases Society of America...

2012

This information sheet discusses treatment for latent TB infection using isoniazid. It reminds patients to of thinks they need to do while taking this drug, including contacting the clinician if they have questions, keeping appointments and what to discuss at the appointments, adhering to the treatment regimen, and informing other physicians about the treatment...

Persons With LTBI
2012